Haibin Dai

28PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Biomolecular modelling and designPharmacogenomicsMedical infection agents (incl. prions)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 28, 2026
Tivozanib versus Sorafenib as Subsequent-Line Therapy for Advanced Renal Cell Carcinoma: A Cost-Effectiveness Analysis from a US Healthcare Perspective.

|Jan 06, 2026
Measuring and locating the changes in protein structure using MELO.

Lingyan Zheng, Yang Liao, Yintao Zhang

|Dec 15, 2025
Efficacy and Safety of Clobazam Adjunctive Therapy in Pediatric Patients with Drug-Resistant Epilepsy.

Lingyan Yu, Shunan Chen, Zhou Zhang

|Nov 27, 2025
Dosing Optimization of Lamotrigine in Peripregnancy Epilepsy Through PopPK Modelling and Simulation.

Jiping Huo, Yilin Liu, Jiayu Yang

|Nov 06, 2025
Variations in ventricular distribution of polymyxin B following intraventricular administration in patients with central nervous system infections.

Huifang Jiang, Yangmin Hu, Jing Cai

|Oct 30, 2025
Dynamic clinical trial success rates for drugs in the 21st century.

Ying Zhou, Yintao Zhang, Hangwei Xu

Pageof 5

Frequent Collaborators

3 joint publications

Lingyan Yu

2 joint publications

Yi Wang

2 joint publications

Zhong Chen

2 joint publications

Feng Zhu